Related Experiment Video
Updated: Sep 27, 2026

Using Adeno-associated Virus as a Tool to Study Retinal Barriers in Disease
Published on: April 19, 2015
Adenosine A1 receptor-mediated inhibition of adenylate cyclase in rabbit retina
Abstract:
The purine adenosine has been postulated as playing a role in CNS neurotransmission or modulation. Evidence is now provided that inhibition of adenylate cyclase in rabbit retinal homogenates is mediated via adenosine A1 receptors. Nanomolar concentrations of the A1 receptor agonists, cyclohexyladenosine (CHA) and phenylisopropyladenosine (PIA), significantly inhibited the activity of forskolin-stimulated adenylate cyclase in preparations in which endogenous adenosine was destroyed by pretreatment with adenosine deaminase. With increasing concentrations of either agonist, biphasic effects on enzyme activity were observed. The effect of the mixed A1-A2 agonist, N-ethyl-carboxamidoadenosine (NECA), on forskolin-stimulated, as well as basal adenylate cyclase, was also investigated. At micromolar concentrations, NECA significantly increased the activity of adenylate cyclase. Isobutylmethylxanthine, a potent antagonist at extracellular adenosine receptors, blocked the effects observed with PIA, CHA, and NECA. The uptake of both 3H-CHA and 3H-adenosine into retinal cells was demonstrated autoradiographically. Both agonists labeled ganglion cell bodies and certain cell bodies located in the proximal portion of the inner nuclear layer.
Related Concept Videos
G-Protein Gated Ion Channels
Sensory organs,...
GPCRs Regulate Adenylyl Cylase Activity
Two...
cAMP-dependent Protein Kinase Pathways
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
Antihypertensive Drugs: Angiotensin II Receptor Blockers

